Similarly, Receiver-operator curve analysis demonstrated that the likelihood of an individual improving (on the Composite z-score and Executive Factor z-score) was significantly greater in the 250 mg PBT2 group (and approached significance for the ADAS-cog—which also showed a trend to improvement in the high dose PBT2 group, as compared to placebo, in the original report).
1
—
—